Viz.ai vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Viz.ai applies AI to medical imaging to detect critical conditions and automatically coordinate care teams, reducing time from diagnosis to treatment for stroke and other emergencies.
About
Viz.ai is a healthcare AI company founded in 2016 that applies computer vision and AI to medical imaging to detect critical conditions and automate care coordination workflows. The platform analyzes CT scans and other medical images in real time, identifying conditions including large vessel occlusion stroke, pulmonary embolism, aortic dissection, and incidental findings, then automatically notifying and coordinating the relevant specialists through a HIPAA-compliant communication platform. Viz.ai has received FDA clearance for over 20 AI algorithms and is deployed at over 1,400 hospital sites across the United States. The company raised over $250M at a $1.2B valuation and has demonstrated that AI-powered care coordination reduces door-to-treatment time for stroke by tens of minutes, which translates directly into better patient outcomes. The platform creates a connected care team workflow where radiologists, neurologists, ER physicians, and interventionalists are automatically looped in when a critical finding is detected. Viz.ai serves as essential care coordination infrastructure for time-sensitive conditions where rapid multi-specialty response is critical to preventing death or disability.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.